- $3.77bn
- $4.27bn
- $1.83bn
- 80
- 23
- 29
- 40
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 95.68 | ||
| PEG Ratio (f) | 2.45 | ||
| EPS Growth (f) | 64.14% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.17 | ||
| Price to Tang. Book | 34.15 | ||
| Price to Free Cashflow | 83.79 | ||
| Price to Sales | 2.06 | ||
| EV to EBITDA | 14.71 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.28% | ||
| Return on Equity | 0.36% | ||
| Operating Margin | 5.04% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1,071.84 | 1,315.08 | 1,430.06 | 1,616.63 | 1,829.66 | 1,934.96 | 2,109.66 | 9.65% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | -48.83 | -89.98 | +840.15 | +59.33 | +70.63 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
RadNet, Inc. is a national provider of fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States. It has a network of 398 owned and/or operated outpatient imaging centers. The Company’s Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The Company’s Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate and pulmonary diagnostics. This segment also designs the underlying critical scheduling, data storage and retrieval systems necessary for imaging center operation.
Directors
- Howard Berger CHM (75)
- Mark Stolper CFO (49)
- Stephen Forthuber CEX (60)
- Norman Hames CEX (65)
- Mital Patel EVF (35)
- Ranjan Jayanathan EVP (65)
- David Katz EVP (57)
- Michael Murdock EVP (66)
- Ruth Wilson SVP (58)
- Christine Gordon SVP (58)
- John Crues VPR (71)
- David Swartz LED (77)
- Laura Jacobs IND (64)
- Lawrence Levitt IND (78)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 19th, 2008
- Public Since
- December 12th, 2001
- No. of Shareholders
- 865
- No. of Employees
- 8,546
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
NASDAQ Global Market- Shares in Issue
- 74,945,616
- Address
- 1510 Cotner Ave, LOS ANGELES, 90025
- Web
- https://www.radnet.com/
- Phone
- +1 3104787808
- Auditors
- Ernst & Young LLP
Upcoming Events for RDNT
Q1 2025 RadNet Inc Earnings Call
RadNet Inc Annual Shareholders Meeting
Q2 2025 RadNet Inc Earnings Release
Similar to RDNT
Airsculpt Technologies
NASDAQ Global Market
Biodesix
NASDAQ Global Market
Burning Rock Biotech
NASDAQ Global Market
Exagen
NASDAQ Global Market
Fulgent Genetics
NASDAQ Global Market
FAQ
What is the Radnet share price?
As of Today at 22:50 UTC, shares in Radnet are trading at $50.26. This share price information is delayed by 15 minutes.
How has the Radnet share price performed this year?
Shares in Radnet last closed at $50.26 and the price had moved by +2.89% over the past 365 days. In terms of relative price strength the Radnet share price has underperformed the S&P500 Index by -5.03% over the past year.
What are the analyst and broker recommendations for Radnet?
The overall consensus recommendation for Radnet is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Radnet dividend yield?
Radnet does not currently pay a dividend.
Does Radnet pay a dividend?
Radnet does not currently pay a dividend.
When does Radnet next pay dividends?
Radnet does not currently pay a dividend.
How do I buy Radnet shares?
To buy shares in Radnet you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Radnet?
As of the previous close price of $50.26, shares in Radnet had a market capitalisation of $3.77bn.
Where are Radnet shares listed?
Here are the trading details for Radnet:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: RDNT
What kind of share is Radnet?
Based on an overall assessment of its quality, value and momentum Radnet is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Radnet share price forecast for 2025?
The analyst consensus target price for shares in Radnet is $71.67. That is 42.6% above the last closing price of $50.26.
Analysts covering Radnet currently have a consensus Earnings Per Share (EPS) forecast of $0.43 for the next financial year.
Find out moreWhat is the trend in the Radnet share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Radnet. Over the past six months, its share price has underperformed the S&P500 Index by -20.18%.
As of the last closing price of $50.26, shares in Radnet were trading -21.85% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Radnet PE Ratio?
The Radnet PE ratio based on its reported earnings over the past 12 months is 95.68. The shares last closed at $50.26.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Radnet?
Radnet's management team is headed by:
- Howard Berger - CHM
- Mark Stolper - CFO
- Stephen Forthuber - CEX
- Norman Hames - CEX
- Mital Patel - EVF
- Ranjan Jayanathan - EVP
- David Katz - EVP
- Michael Murdock - EVP
- Ruth Wilson - SVP
- Christine Gordon - SVP
- John Crues - VPR
- David Swartz - LED
- Laura Jacobs - IND
- Lawrence Levitt - IND